(PDF) BMI as Predictor of Adverse Outcomes With Moderate

BMI as Predictor of Adverse Outcomes With Moderate Intravenous Sedation During Surgical Abortion

Contraception - United States

doi 10.1016/j.contraception.2016.07.025

Full Text

Abstract

Available in full text

Categories

Reproductive Medicine

Date

October 1, 2016

Authors

Publisher

Elsevier BV

Related search

Association of BMI With Propofol Dosing and Adverse Events in Children With Cancer Undergoing Procedural Sedation

Hospital pediatrics

English

Intravenous Sedation

Kokubyo Gakkai zasshi. The Journal of the Stomatological Society, Japan

English

Advanced Monitoring Is Associated With Fewer Alarm Events During Planned Moderate Procedure-Related Sedation

Anesthesia and Analgesia

English

Cardiorespiratory Complications During Moderate and Deep Sedation for Gastrointestinal Endoscopic Procedures

English

Dexmedetomidine-Midazolam Sedation Reduces Unexpected Patient Movement During Dental Surgery as Compared With Propofol-Midazolam Sedation.

Journal of Oral and Maxillofacial Surgery

Otorhinolaryngology

English

A Comparison of Fospropofol to Midazolam for Moderate Sedation During Outpatient Dental Procedures

Anesthesia Progress

English

Higher Mallampati Scores Are Not Associated With More Adverse Events During Pediatric Procedural Sedation and Analgesia

Western Journal of Emergency Medicine

Emergency Medicine

English

Hypercholesterolaemia in Pregnancy as a Predictor of Adverse Pregnancy Outcome

African Health Sciences

English

Brain Natriuretic Peptide as a Predictor of Adverse Outcome in Patients With Pulmonary Embolism

Cardiovascular Medicine

English